J. Kinskey

Early signals of significantly increased vaccine breakthrough, decreased hospitalization rates, and less severe disease in patients with COVID-19 caused by the Omicron variant of SARS-CoV-2 in Houston, Texas

R. Olsen, J. Musser, R. Olson, 2022, medRxiv.

Delta Variants of SARS-CoV-2 Cause Significantly Increased Vaccine Breakthrough COVID-19 Cases in Houston, Texas

James J. Davis, M. Nguyen, S. W. Long, 2021, The American Journal of Pathology.

Signals of Significantly Increased Vaccine Breakthrough, Decreased Hospitalization Rates, and Less Severe Disease in Patients with Coronavirus Disease 2019 Caused by the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 in Houston, Texas

James J. Davis, S. W. Long, R. Olsen, 2022, The American Journal of Pathology.

T-cell receptor-β V and J usage, in combination with particular HLA class I and class II alleles, correlates with cancer survival patterns

T. Fawcett, Y. Tu, G. Blanck, 2018, Cancer Immunology, Immunotherapy.

Recovery of Immunoglobulin VJ Recombinations from Pancreatic Cancer Exome Files Strongly Correlates with Reduced Survival

Y. Tu, G. Blanck, John M. Yavorski, 2018, Cancer Microenvironment.

Bacterial Sequencing Reads in Blood Exome Files from Melanoma and Cervical Cancer Patients are Associated with Cancer Recurrence

G. Blanck, Saif Zaman, Michael J. Diaz, 2023, Molecular Biotechnology.

Delta variants of SARS-CoV-2 cause significantly increased 1 vaccine breakthrough COVID-19 cases in Houston, Texas 2

M. Nguyen, S. W. Long, R. Olsen, 2021 .

Delta variants of SARS-CoV-2 cause significantly increased 1 vaccine breakthrough COVID-19 cases in Houston, Texas 2

M. Nguyen, S. W. Long, R. Olsen, 2021 .